{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:02:19Z","timestamp":1776398539173,"version":"3.51.2"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009871","name":"AcelRx Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bpa.2021.02.003","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T12:50:02Z","timestamp":1614603002000},"page":"437-448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes"],"prefix":"10.1016","volume":"35","author":[{"given":"Alan D.","family":"Kaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allyson L.","family":"Spence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariah","family":"Mayerle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitish","family":"Sardana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire M.","family":"Clay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus M.","family":"Luedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle A.","family":"Carroll Turpin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Urman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyse M.","family":"Cornett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bpa.2021.02.003_bib1","article-title":"A\u00a0review of acute myocardial injury in coronavirus disease 2019","volume":"12","author":"Anupama","year":"2020","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.bpa.2021.02.003_bib2","article-title":"Impact of COVID-19 on the cardiovascular system: a review","volume":"9","author":"Matsushita","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.bpa.2021.02.003_bib3","series-title":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options","author":"Guzik","year":"2020"},{"issue":"19","key":"10.1016\/j.bpa.2021.02.003_bib4","first-page":"17","article-title":"An overview of the World current and future assessment of novel COVID-19 trajectory, impact, and potential preventive strategies at healthcare settings","volume":"25","author":"Al-Anzi","year":"2020","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.bpa.2021.02.003_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijsu.2020.04.018","article-title":"The socio-economic implications of the coronavirus pandemic (COVID-19): a review","volume":"78","author":"Nicola","year":"2020","journal-title":"Int J Surg Lond Engl"},{"issue":"5","key":"10.1016\/j.bpa.2021.02.003_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.dsx.2020.05.035","article-title":"Psychosocial impact of COVID-19","volume":"14","author":"Dubey","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"10.1016\/j.bpa.2021.02.003_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/joim.13091","article-title":"COVID-19 diagnosis and management: a comprehensive review","volume":"288","author":"Pascarella","year":"2020","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.bpa.2021.02.003_bib9","first-page":"100583","article-title":"Association between COVID-19 and cardiovascular disease","volume":"29","author":"Srivastava","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"6","key":"10.1016\/j.bpa.2021.02.003_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11912-020-00945-4","article-title":"The COVID-19 pandemic and its impact on the cardio-oncology population","volume":"22","author":"Asokan","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.bpa.2021.02.003_bib11","first-page":"100557","article-title":"Coronavirus disease 2019 and cardiovascular system: a narrative review","volume":"29","author":"Kwenandar","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"6","key":"10.1016\/j.bpa.2021.02.003_bib12","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/jocs.14538","article-title":"Cardiac involvement in COVID-19 patients: risk factors, predictors, and complications: a review","volume":"35","author":"Aghagoli","year":"2020","journal-title":"J\u00a0Card Surg"},{"issue":"23","key":"10.1016\/j.bpa.2021.02.003_bib13","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1161\/CIRCULATIONAHA.120.047349","article-title":"Description and proposed management of the acute COVID-19 cardiovascular syndrome","volume":"141","author":"Hendren","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.bpa.2021.02.003_bib14","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.bpa.2021.02.003_bib15","first-page":"1","article-title":"Impact of COVID-19 on the cardiovascular system: a review of available reports","author":"Soumya","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"issue":"8","key":"10.1016\/j.bpa.2021.02.003_bib16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/JCMA.0000000000000352","article-title":"Cardiovascular manifestation and treatment in COVID-19","volume":"83","author":"Su","year":"2020","journal-title":"J\u00a0Chin Med Assoc JCMA"},{"issue":"18","key":"10.1016\/j.bpa.2021.02.003_bib17","article-title":"Clinical characteristics and risk factors of cardiac involvement in COVID-19","volume":"9","author":"Xu","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.bpa.2021.02.003_bib18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.bpa.2021.02.003_bib19","volume":"9","author":"Guo","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.bpa.2021.02.003_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bbrc.2020.05.203","article-title":"Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke","volume":"528","author":"Choi","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"23","key":"10.1016\/j.bpa.2021.02.003_bib21","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1001\/jama.2020.8707","article-title":"Nasal gene expression of angiotensin-converting enzyme 2 in children and adults","volume":"323","author":"Bunyavanich","year":"2020","journal-title":"J\u00a0Am Med Assoc"},{"issue":"33","key":"10.1016\/j.bpa.2021.02.003_bib22","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1093\/eurheartj\/ehaa583","article-title":"ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19","volume":"41","author":"Lupi","year":"2020","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.bpa.2021.02.003_bib23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41440-020-0476-3","article-title":"Downregulation of ACE2 induces overstimulation of the renin\u2013angiotensin system in COVID-19: should we block the renin\u2013angiotensin system?","volume":"43","author":"Silhol","year":"2020","journal-title":"Hypertens Res"},{"issue":"11","key":"10.1016\/j.bpa.2021.02.003_bib24","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/ndt\/gfm614","article-title":"Angiotensin AT1 and AT2 receptors the battle for health and disease","volume":"22","author":"Siragy","year":"2007","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.bpa.2021.02.003_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.05.008","article-title":"AT1 receptor signaling pathways in the cardiovascular system","volume":"125","author":"Kawai","year":"2017","journal-title":"Pharmacol Res"},{"issue":"11","key":"10.1016\/j.bpa.2021.02.003_bib26","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s11695-020-04734-7","article-title":"Obesity and COVID-19: ACE 2, the missing tile","volume":"30","author":"Iannelli","year":"2020","journal-title":"Obes Surg"},{"issue":"7","key":"10.1016\/j.bpa.2021.02.003_bib27","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/oby.22831","article-title":"High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation","volume":"28","author":"Simonnet","year":"2020","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.bpa.2021.02.003_bib28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.0000154361.47683.d3","article-title":"Weight loss and the renin-angiotensin-aldosterone system","volume":"45","author":"Engeli","year":"2005","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.bpa.2021.02.003_bib29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","article-title":"COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives","volume":"17","author":"Nishiga","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.bpa.2021.02.003_bib30","doi-asserted-by":"crossref","first-page":"102452","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","volume":"111","author":"Liu","year":"2020","journal-title":"J\u00a0Autoimmun"},{"issue":"7","key":"10.1016\/j.bpa.2021.02.003_bib31","doi-asserted-by":"crossref","first-page":"1547.e5","DOI":"10.1016\/j.ajem.2020.04.080","article-title":"COVID-19 myopericarditis: it should be kept in mind in today's conditions","volume":"38","author":"Cizgici","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.bpa.2021.02.003_bib32","doi-asserted-by":"crossref","first-page":"100589","DOI":"10.1016\/j.ijcha.2020.100589","article-title":"COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management","volume":"29","author":"Sattar","year":"2020","journal-title":"IJC Heart Vasc"},{"key":"10.1016\/j.bpa.2021.02.003_bib33","volume":"vol. 10","author":"Kakihana","year":"2016"},{"issue":"23","key":"10.1016\/j.bpa.2021.02.003_bib34","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1161\/CIRCULATIONAHA.120.047349","article-title":"Description and proposed management of the acute COVID-19 cardiovascular syndrome","volume":"141","author":"Hendren","year":"2020","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bpa.2021.02.003_bib35","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamacardio.2020.3551","article-title":"Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases","volume":"5","author":"Lindner","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.bpa.2021.02.003_bib36","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","article-title":"Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)","volume":"5","author":"Puntmann","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.bpa.2021.02.003_bib37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11239-020-02266-6","article-title":"Anticipating the long-term cardiovascular effects of COVID-19","volume":"50","author":"Becker","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.bpa.2021.02.003_bib38","series-title":"COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup","volume":"18","author":"Nadim","year":"2020"},{"issue":"1","key":"10.1016\/j.bpa.2021.02.003_bib39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2337\/dc20-1714","article-title":"Metabolic syndrome and COVID-19 mortality among adult black patients in new Orleans","volume":"44","author":"Xie","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpa.2021.02.003_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.trsl.2017.01.001","article-title":"Cardiovascular consequences of metabolic syndrome","volume":"183","author":"Tune","year":"2017","journal-title":"Transl Res"},{"issue":"1","key":"10.1016\/j.bpa.2021.02.003_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12265-020-10006-7","article-title":"Chemokines in myocardial infarction","volume":"14","author":"Chen","year":"2021","journal-title":"J\u00a0Cardiovasc Transl Res"},{"issue":"11","key":"10.1016\/j.bpa.2021.02.003_bib42","doi-asserted-by":"crossref","first-page":"801","DOI":"10.34172\/aim.2020.107","article-title":"Acute cardiac injury in COVID-19: a systematic review and meta-analysis","volume":"23","author":"Vakhshoori","year":"2020","journal-title":"Arch Iran Med"},{"issue":"15","key":"10.1016\/j.bpa.2021.02.003_bib43","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/heartjnl-2020-317007","article-title":"Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis","volume":"106","author":"Wei","year":"2020","journal-title":"Heart"},{"issue":"18","key":"10.1016\/j.bpa.2021.02.003_bib44","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.bpa.2021.02.003_bib45","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1161\/CIRCULATIONAHA.118.038529","article-title":"Cardiac troponin T and troponin I in the general population: comparing and contrasting their genetic determinants and associations with outcomes","volume":"139","author":"Welsh","year":"2019","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.bpa.2021.02.003_bib46","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1515\/cclm-2020-0198","article-title":"Laboratory abnormalities in patients with COVID-2019 infection","volume":"58","author":"Lippi","year":"2020","journal-title":"Clin Chem Lab Med CCLM"},{"issue":"7","key":"10.1016\/j.bpa.2021.02.003_bib47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"9","key":"10.1016\/j.bpa.2021.02.003_bib48","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s42399-020-00454-2","article-title":"Arrhythmia in COVID-19","volume":"2","author":"Babapoor-Farrokhran","year":"2020","journal-title":"SN Compr Clin Med"},{"issue":"11","key":"10.1016\/j.bpa.2021.02.003_bib49","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"J\u00a0Am Med Assoc"},{"issue":"2","key":"10.1016\/j.bpa.2021.02.003_bib50","first-page":"e139","article-title":"Cardiovascular complications in COVID-19: a systematic review and meta-analysis","volume":"81","author":"Kunutsor","year":"2020","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.bpa.2021.02.003_bib51","doi-asserted-by":"crossref","first-page":"100685","DOI":"10.1016\/j.ijcha.2020.100685","article-title":"Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan","volume":"32","author":"Maneikis","year":"2021","journal-title":"IJC Heart Vasc"},{"key":"10.1016\/j.bpa.2021.02.003_bib52","doi-asserted-by":"crossref","first-page":"m1091","DOI":"10.1136\/bmj.m1091","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","author":"Chen","year":"2020","journal-title":"BMJ"},{"issue":"10229","key":"10.1016\/j.bpa.2021.02.003_bib53","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet Lond Engl"},{"issue":"21","key":"10.1016\/j.bpa.2021.02.003_bib54","doi-asserted-by":"crossref","first-page":"E583","DOI":"10.1503\/cmaj.200685","article-title":"Coagulopathy associated with COVID-19","volume":"192","author":"Lee","year":"2020","journal-title":"Can Med Assoc J"},{"issue":"1","key":"10.1016\/j.bpa.2021.02.003_bib55","first-page":"140","article-title":"Coagulative disorders in critically ill COVID-19 patients with acute distress respiratory syndrome: a critical review","volume":"10","author":"Robba","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.bpa.2021.02.003_bib56","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.thromres.2018.07.003","article-title":"The HIV protease inhibitor, ritonavir, dysregulates human platelet function in\u00a0vitro","volume":"169","author":"Loelius","year":"2018","journal-title":"Thromb Res"},{"issue":"22","key":"10.1016\/j.bpa.2021.02.003_bib57","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMra1208707","article-title":"Ventilator-induced lung injury","volume":"369","author":"Slutsky","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.bpa.2021.02.003_bib58","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"18","key":"10.1016\/j.bpa.2021.02.003_bib59","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpa.2021.02.003_bib60","first-page":"1","article-title":"Hematologic disorders associated with COVID-19: a review","author":"Rahi","year":"2021","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.bpa.2021.02.003_bib61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.bpa.2021.02.003_bib62","first-page":"1","article-title":"Impact of COVID-19 on the cardiovascular system: a review of available reports","author":"Soumya","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.bpa.2021.02.003_bib63","series-title":"Macrophages [Internet]","first-page":"299","article-title":"Macrophage dysfunction in respiratory disease","author":"Belchamber","year":"2017"},{"key":"10.1016\/j.bpa.2021.02.003_bib64","doi-asserted-by":"crossref","first-page":"100557","DOI":"10.1016\/j.ijcha.2020.100557","article-title":"Coronavirus disease 2019 and cardiovascular system: a narrative review","volume":"29","author":"Kwenandar","year":"2020","journal-title":"IJC Heart Vasc"},{"key":"10.1016\/j.bpa.2021.02.003_bib65","series-title":"Aveolar macrophage activation and cytokine storm in the pathogenesis of severe COVID-19","author":"Wang","year":"2020"},{"issue":"1","key":"10.1016\/j.bpa.2021.02.003_bib66","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41371-020-0387-4","article-title":"Covid-19 and the cardiovascular system: a comprehensive review","volume":"35","author":"Azevedo","year":"2020","journal-title":"J\u00a0Hum Hypertens"},{"issue":"7","key":"10.1016\/j.bpa.2021.02.003_bib67","doi-asserted-by":"crossref","first-page":"102573","DOI":"10.1016\/j.autrev.2020.102573","article-title":"COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome?","volume":"19","author":"Colafrancesco","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.bpa.2021.02.003_bib68","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.bpa.2021.02.003_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflamm Regen"},{"issue":"8","key":"10.1016\/j.bpa.2021.02.003_bib70","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1634\/theoncologist.2018-0028","article-title":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome","volume":"23","author":"Le","year":"2018","journal-title":"The Oncologist"},{"key":"10.1016\/j.bpa.2021.02.003_bib71","unstructured":"National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. :251."},{"key":"10.1016\/j.bpa.2021.02.003_bib72","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjcard.2020.09.012","article-title":"Relation of statin use prior to admission to severity and recovery among COVID-19 inpatients","volume":"136","author":"Daniels","year":"2020","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.bpa.2021.02.003_bib73","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/505116","article-title":"Pandemic influenza: a potential role for statins in treatment and prophylaxis","volume":"43","author":"Fedson","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"10234","key":"10.1016\/j.bpa.2021.02.003_bib74","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bpa.2021.02.003_bib75","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.atherosclerosis.2020.10.014","article-title":"Endothelial dysfunction in COVID-19: current findings and therapeutic implications","volume":"314","author":"N\u00e4gele","year":"2020","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.bpa.2021.02.003_bib76","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","article-title":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options","volume":"116","author":"Guzik","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"17","key":"10.1016\/j.bpa.2021.02.003_bib77","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.bpa.2021.02.003_bib78","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","article-title":"Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people","volume":"106","author":"Hippisley-Cox","year":"2020","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.bpa.2021.02.003_bib79","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","article-title":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor\u2013dependent mechanism","volume":"64","author":"Deshotels","year":"2014","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.bpa.2021.02.003_bib80","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.11122","article-title":"Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease 2019 in Wenzhou, China","volume":"3","author":"Chen","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.bpa.2021.02.003_bib81","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1111\/j.1755-5922.2010.00258.x","article-title":"Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: hyperkalemia with ACEI and ARB","volume":"30","author":"Raebel","year":"2012","journal-title":"Cardiovasc Ther"},{"issue":"7","key":"10.1016\/j.bpa.2021.02.003_bib82","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.bpa.2021.02.003_bib83","first-page":"e6","article-title":"Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19","volume":"81","author":"Liu","year":"2020","journal-title":"J\u00a0Infect"},{"issue":"7","key":"10.1016\/j.bpa.2021.02.003_bib84","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00277-020-04103-5","article-title":"Hematological findings in coronavirus disease 2019: indications of progression of disease","volume":"99","author":"Liu","year":"2020","journal-title":"Ann Hematol"},{"issue":"7","key":"10.1016\/j.bpa.2021.02.003_bib85","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID -19","volume":"95","author":"Terpos","year":"2020","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.bpa.2021.02.003_bib86","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"58","author":"Henry","year":"2020","journal-title":"Clin Chem Lab Med CCLM"},{"issue":"6","key":"10.1016\/j.bpa.2021.02.003_bib87","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00003246-200006000-00031","article-title":"Thrombocytopenia and prognosis in intensive care","volume":"28","author":"Vanderschueren","year":"2000","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.bpa.2021.02.003_bib88","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4103\/ijccm.IJCCM_279_17","article-title":"Thrombocytopenia in critically ill patients: clinical and laboratorial behavior and its correlation with short-term outcome during hospitalization","volume":"21","author":"Khurana","year":"2017","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.bpa.2021.02.003_bib89","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.bpa.2021.02.003_bib90","article-title":"COVID-19 in recent heart transplant recipients: clinicopathologic features and early outcomes","volume":"22","author":"Lima","year":"2020","journal-title":"Transpl Infect Dis Off J Transpl Soc"},{"key":"10.1016\/j.bpa.2021.02.003_bib91","first-page":"e202159","article-title":"Characteristics and outcomes of recipients of heart transplant with coronavirus disease 2019","author":"Latif","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.bpa.2021.02.003_bib92","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.healun.2020.03.008","article-title":"Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: a descriptive survey report","volume":"39","author":"Ren","year":"2020","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"12","key":"10.1016\/j.bpa.2021.02.003_bib93","first-page":"1531","article-title":"COVID-19 among heart transplant recipients in Germany: a multicenter survey","volume":"109","author":"Rivinius","year":"2020","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"issue":"7","key":"10.1016\/j.bpa.2021.02.003_bib94","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/ajt.15936","article-title":"COVID-19 in a high-risk dual heart and kidney transplant recipient","volume":"20","author":"Hsu","year":"2020","journal-title":"Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg"}],"container-title":["Best Practice & Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689621000082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689621000082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:38:38Z","timestamp":1776397118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689621000082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1521689621000082"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2021.02.003","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2021.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}